These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 24902139)

  • 1. Malaria in a returning traveler from Jamaica.
    Kavanaugh M; Bavaro M
    Mil Med; 2014 Jun; 179(6):e697-8. PubMed ID: 24902139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A malarial attack on return from a voyage to the French Antilles. Discussion of the mode of transmission].
    Poinsignon Y; Arfi C; Sarfati C; Farge-Bancel D; Raccurt CP
    Med Trop (Mars); 1999; 59(1):55-7. PubMed ID: 10472584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza-like illness as an atypical presentation of falciparum malaria in a traveler from Africa.
    Sandhu G; Ranade A; Ramsinghani P; Noel C
    J Emerg Med; 2011 Jul; 41(1):35-8. PubMed ID: 20456900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of atovaquone/proguanil to prevent Plasmodium ovale malaria in traveler returning from Cameroon.
    Gallien S; Taieb F; Schlemmer F; Lagrange-Xelot M; Atlan A; Sarfati C; Molina JM
    Travel Med Infect Dis; 2008 May; 6(3):128-9. PubMed ID: 18486067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tolerance and efficacy of atovaquone-proguanil for the treatment of paediatric imported Plasmodium falciparum malaria in France: clinical practice in a university hospital in Paris].
    Blondé R; Naudin J; Bigirimana Z; Holvoet L; Fenneteau O; Vitoux C; Bourdon O; Angoulvant F; Lorrot M; D'Ortenzio E; Bourrillon A; Le Bras J; Matheron S; Faye A
    Arch Pediatr; 2008 Mar; 15(3):245-52. PubMed ID: 18321692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected].
    van Genderen PJ; Koene HR; Spong K; Overbosch D
    J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum malaria recrudescence occurring 2.5 years after leaving an endemic country.
    Berrevoets MA; Sprong T; Meis JF; Dofferhoff AS
    Neth J Med; 2013 Oct; 71(8):426-8. PubMed ID: 24127503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum malaria occurring four years after leaving an endemic area.
    Vantomme B; Van Acker J; Rogge S; Ommeslag D; Donck J; Callens S
    Acta Clin Belg; 2016 Apr; 71(2):111-3. PubMed ID: 26312505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atovaquone and proguanil hydrochloride for prophylaxis of malaria.
    Shanks GD; Kremsner PG; Sukwa TY; van der Berg JD; Shapiro TA; Scott TR; Chulay JD;
    J Travel Med; 1999 May; 6 Suppl 1():S21-7. PubMed ID: 23573549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone/proguanil for the prophylaxis and treatment of malaria.
    Patel SN; Kain KC
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):849-61. PubMed ID: 16307498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An imported case of severe falciparum malaria with prolonged hemolytic anemia clinically mimicking a coinfection with babesiosis.
    Na YJ; Chai JY; Jung BK; Lee HJ; Song JY; Je JH; Seo JH; Park SH; Choi JS; Kim MJ
    Korean J Parasitol; 2014 Dec; 52(6):667-72. PubMed ID: 25548419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malaria surveillance--United States, 2006.
    Mali S; Steele S; Slutsker L; Arguin PM;
    MMWR Surveill Summ; 2008 Jun; 57(5):24-39. PubMed ID: 18566568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subacute clinical forms of Plasmodium falciparum malaria in travelers receiving chloroquine-proguanil prophylaxis.
    Klement E; Chauveheid MP; Thellier M; Bricaire F; Danis M; Caumes E
    Clin Infect Dis; 2001 Jul; 33(1):e1-2. PubMed ID: 11389510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of adherence to atovaquone-proguanil prophylaxis in travelers.
    DePetrillo JC; Singer C; Bergagnini IA; Kolakowski P; Edwards B; Smith MA
    J Travel Med; 2010; 17(4):217-20. PubMed ID: 20636593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria surveillance--United States, 2012.
    Cullen KA; Arguin PM;
    MMWR Surveill Summ; 2014 Dec; 63(12):1-22. PubMed ID: 25474160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of short prophylactic course of atovaquone-proguanil in travelers to sub-saharan Africa.
    Leshem E; Meltzer E; Stienlauf S; Kopel E; Schwartz E
    J Travel Med; 2014; 21(2):82-5. PubMed ID: 24298915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atovaquone and proguanil hydrochloride for treatment of malaria.
    Kremsner PG; Looareesuwan S; Chulay JD
    J Travel Med; 1999 May; 6 Suppl 1():S18-20. PubMed ID: 23573548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria acquired in Haiti - 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Mar; 59(8):217-9. PubMed ID: 20203553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Deadly Wait for U.S. Health Insurance Coverage-Sitting on the Couch with Malaria.
    Schultz JS; Atherly AJ; Henao-Martínez AF
    Am J Trop Med Hyg; 2018 Jul; 99(1):24-26. PubMed ID: 29761755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.